Generative artificial intelligence could take years off the time between identifying public health risks and launching ...

Insilico plans late-stage trials for rentosertib following positive mid-stage safety and efficacy data for idiopathic ...

As of the cut-off date of April 2, 2025, a total of 21 patients had been enrolled and received at least one dose of PAS-004 ...

Three BriaCell posters and one publish-only abstract highlight robust clinical data from Bria-IMT™ and Bria-OTS™ studies in metastatic breast cancer (MBC) Median Overall Survival of 17.3 months in ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

Two groundbreaking biotechnology advances are fundamentally altering human health and food production in 2025, moving from ...

Zivanov, assistant professor of electrical and computer engineering, has received a prestigious Faculty Early Career ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.caNews Commentary – As traditional research institutions ...

Smart-thinking young people at St Aidan’s High in Wishaw are finalists in this year’s Big Bang UK Young Scientists & ...

Clinical validation of the Azymetric platform is demonstrated by the accelerated approval our partner Jazz Pharmaceuticals received from the U.S. Food and Drug Administration in 2024 for Ziihera® ...

Final CM24 Phase 2 data presented at AACR Annual Meeting 2025, strengthening patient selection strategy for CM24 Phase 2b study planned to be initiated in Second Half of 2025 NT219 data presented at ...